Weight Loss/Obesity
Show Only Open Trials
1.
Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess Short-term Safety and Tolerability of Lorcaserin + Two Doses of Immediate-Release Phentermine-HCl Compared w/ Lorcaserin Alone in Overweight & Obese Adults
- Study Status: Open to Enrollment
- Sponsor: Eisai Inc.
- Disease Status and/or Stage: Weight Loss/Obesity
- Protocol ID: WCMC IRB # 1310014369; Eisai Protocol # APD356-A001-402
2.
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Comparing the EndoBarrier® Gastrointestinal Liner System vs. Sham for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects on Oral Anti-Diabetes Agents
- Study Status: Open to Enrollment
- Sponsor: GI Dynamics
- Disease Status and/or Stage: Overweight with Type 2 Diabetes
3.
Pivotal Aspiration Therapy with Adjusted Lifestyle Study (PATHWAY)
- Study Status: Open to Enrollment
- Sponsor: Aspire Bariatrics
- Disease Status and/or Stage: Obesity
4.
SCALE: SMALL CHANGES AND LASTING EFFECTS
- Study Status: Open to Enrollment
- Sponsor: NIH/NHLBI
